INIS CEO receives 37.5M performance-based RSUs per Form 4

Rhea-AI Filing Summary

International Isotopes Inc. (INIS) reported an insider equity award on Form 4. President & CEO and director Shahe Bagerdjian received 37,500,000 restricted stock units (RSUs) on October 9, 2025 under the company’s Amended and Restated 2015 Incentive Plan.

Each RSU represents a contingent right to receive one share of INIS common stock. The RSUs vest based on milestones tied to the company’s share price and available cash. Following the transaction, the filing shows 37,500,000 derivative securities beneficially owned, held directly, with a stated price of $0 for the RSUs.

Insights

Equity Compensation Analyst

Large performance-based RSU grant to the CEO; neutral impact.

The filing lists an award of 37,500,000 RSUs to the CEO, each convertible into one share upon vesting. The grant is under the company’s 2015 Incentive Plan and uses performance milestones linked to share price and available cash, aligning equity delivery with specified outcomes.

Because vesting depends on achieving these metrics, actual share delivery is contingent. Beneficial ownership of 37,500,000 derivative securities is shown as direct, with a stated RSU price of $0. The practical impact will depend on milestone attainment and subsequent settlement terms disclosed in future materials.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Bagerdjian Shahe

(Last) (First) (Middle)

4137 COMMERCE CIRCLE

(Street)

IDAHO FALLS ID 83401

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTERNATIONAL ISOTOPES INC [ INIS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres. & CEO

3. Date of Earliest Transaction (Month/Day/Year)
10/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	10/09/2025		A		37,500,000		(2)	(2)	Common Stock	37,500,000	$0	37,500,000	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of INIS common stock.

2. The restricted stock units have been granted under the issuer's Amended and Restated 2015 Incentive Plan and vest in accordance with a milestone schedule based on meeting certain metrics related to the issuer's share price and available cash of the issuer.

	/s/ Shahe Bagerdjian	10/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did INIS disclose on Form 4?

The CEO and director, Shahe Bagerdjian, received 37,500,000 restricted stock units on October 9, 2025 under the company’s incentive plan.

How many RSUs were granted to the INIS CEO?

The filing reports a grant of 37,500,000 RSUs, each representing a contingent right to one share of common stock.

What are the vesting conditions for the INIS RSUs (INIS)?

The RSUs vest based on milestones tied to share price and available cash, per the filing.

What is the reported price for the INIS RSUs?

The RSUs are listed with a price of $0 in the Form 4.

How many derivative securities are beneficially owned after the transaction?

The filing shows 37,500,000 derivative securities beneficially owned, held directly.

Under which plan were the INIS RSUs granted?

They were granted under the issuer’s Amended and Restated 2015 Incentive Plan.